Research

LIke ThisLIke ThisLIke This

Alan  Leviton, MD

Alan Leviton
Department:
Neurology Research
Hospital Title:
Director, Neuroepidemiology Unit
Academic Title:
Professor of Neurology, Harvard Medical School
Research Focus Area:
Neuroepidimiology

Research Overview

My research tries to identify why very preterm newborns are at high risk for brain damage. My goal is to identify exposures whose elimination or minimization might reduce the risk for this brain damage and its consequences. I had been the principal investigator of the 14-center ELGAN (Extremely Low Gestational Age Newborns) study, a prospective epidemiologic study of 1,500 infants born before the 28th week of gestation.

The ELGAN investigators seek to identify changes that occur before the brain ultrasound abnormalities that predict motor, cognitive, perceptual and behavior dysfunctions in these children. Much of this study relies on biomarkers measured in the placenta, umbilical cord and blood. Each of the proteins assessed has a role in inflammation, which is linked to oligodendrocyte damage and/or dysfunction or to processes that ameliorate damage/dysfunction.

By identifying biomarkers that indicate increased risk of cerebral damage, the ELGAN study should enable researchers to better design clinical trials of measures to reduce the occurrence of early brain damage and later developmental disabilities.

About Alan Leviton

Alan Leviton received his MD from SUNY-Health Sciences Center at Brooklyn, College of Medicine. He trained in medicine at Kings County Hospital, Brooklyn, NY, in neurology at the Barnes Hospital/Washington University program in St. Louis, MO in neuropathology at Children's Hospital, and in epidemiology at Harvard School of Public Health.

Publications

Publications powered by Harvard Catalyst Profiles
  1. Faden M, Holm M, Allred E, Fichorova R, Dammann O, Leviton A. Antenatal glucocorticoids and neonatal inflammation-associated proteins. Cytokine. 2016 Dec; 88:199-208.
  2. Singh R, Shah B, Allred EN, Grzybowski M, Martin CR, Leviton A. The antecedents and correlates of necrotizing enterocolitis and spontaneous intestinal perforation among infants born before the 28th week of gestation. J Neonatal Perinatal Med. 2016 May 19; 9(2):159-70.
  3. Holm M, Skranes J, Dammann O, Fichorova RN, Allred EN, Leviton A. Systemic endogenous erythropoietin and associated disorders in extremely preterm newborns. Arch Dis Child Fetal Neonatal Ed. 2016 Sep; 101(5):F458-63.
  4. Dammann O, Allred EN, Fichorova RN, Kuban K, O'Shea TM, Leviton A. Duration of Systemic Inflammation in the First Postnatal Month Among Infants Born Before the 28th Week of Gestation. Inflammation. 2016 Apr; 39(2):672-7.
  5. Joseph RM, O'Shea TM, Allred EN, Heeren T, Hirtz D, Jara H, Leviton A, Kuban KC. Neurocognitive and Academic Outcomes at Age 10 Years of Extremely Preterm Newborns. Pediatrics. 2016 Apr; 137(4).
  6. Kuban KC, Joseph RM, O'Shea TM, Allred EN, Heeren T, Douglass L, Stafstrom CE, Jara H, Frazier JA, Hirtz D, Leviton A. Girls and Boys Born before 28 Weeks Gestation: Risks of Cognitive, Behavioral, and Neurologic Outcomes at Age 10 Years. J Pediatr. 2016 Jun; 173:69-75.e1.
  7. van der Burg JW, Leviton A. Reply to Commentary by Strandvik: 'The development of infants born to obese mothers might be related to omega-3 fatty acid status'. Acta Paediatr. 2016 Mar; 105(3):e93.
  8. Leviton A, Allred EN, Fichorova RN, Kuban KC, O'Shea TM, Dammann O. Antecedents of inflammation biomarkers in preterm newborns on days 21 and 28. Acta Paediatr. 2016 Mar; 105(3):274-80.
  9. Leviton A, Allred EN, Kuban KC, O'Shea TM, Paneth N, Onderdonk AB, Fichorova RN, Dammann O. The Development of Extremely Preterm Infants Born to Women Who Had Genitourinary Infections During Pregnancy. Am J Epidemiol. 2016 Jan 1; 183(1):28-35.
  10. Belfort MB, Kuban KC, O'Shea TM, Allred EN, Ehrenkranz RA, Engelke SC, Leviton A. Weight Status in the First 2 Years of Life and Neurodevelopmental Impairment in Extremely Low Gestational Age Newborns. J Pediatr. 2016 Jan; 168:30-5.e2.
  11. Show all
  12. van der Burg JW, Allred EN, Kuban K, O'Shea TM, Dammann O, Leviton A. Maternal obesity and development of the preterm newborn at 2 years. Acta Paediatr. 2015 Sep; 104(9):900-3.
  13. Leviton A, Gressens P, Wolkenhauer O, Dammann O. Systems approach to the study of brain damage in the very preterm newborn. Front Syst Neurosci. 2015; 9:58.
  14. Korzeniewski SJ, Allred E, Logan JW, Fichorova RN, Engelke S, Kuban KC, O'Shea TM, Paneth N, Holm M, Dammann O, Leviton A. Elevated endogenous erythropoietin concentrations are associated with increased risk of brain damage in extremely preterm neonates. PLoS One. 2015; 10(3):e0115083.
  15. Dammann O, Gray P, Gressens P, Wolkenhauer O, Leviton A. Systems Epidemiology: What's in a Name? Online J Public Health Inform. 2014; 6(3):e198.
  16. Korzeniewski SJ, Soto-Rivera CL, Fichorova RN, Allred EN, Kuban KC, O'Shea TM, Paneth N, Agus M, Dammann O, Leviton A. Are preterm newborns who have relative hyperthyrotropinemia at increased risk of brain damage? J Pediatr Endocrinol Metab. 2014 Nov; 27(11-12):1077-88.
  17. Lee JW, VanderVeen D, Allred EN, Leviton A, Dammann O. Prethreshold retinopathy in premature infants with intrauterine growth restriction. Acta Paediatr. 2015 Jan; 104(1):27-31.
  18. Kuban KC, O'Shea TM, Allred EN, Fichorova RN, Heeren T, Paneth N, Hirtz D, Dammann O, Leviton A. The breadth and type of systemic inflammation and the risk of adverse neurological outcomes in extremely low gestation newborns. Pediatr Neurol. 2015 Jan; 52(1):42-8.
  19. Downey LC, O'Shea TM, Allred EN, Kuban K, McElrath TF, Warner DD, Ware J, Hecht JL, Onderdonk A, Leviton A. Antenatal and early postnatal antecedents of parent-reported attention problems at 2 years of age. J Pediatr. 2015 Jan; 166(1):20-5.
  20. Fichorova RN, Beatty N, Sassi RR, Yamamoto HS, Allred EN, Leviton A. Systemic inflammation in the extremely low gestational age newborn following maternal genitourinary infections. Am J Reprod Immunol. 2015 Feb; 73(2):162-74.
  21. Soto-Rivera CL, Fichorova RN, Allred EN, Van Marter LJ, Shah B, Martin CR, Agus MS, Leviton A. The relationship between TSH and systemic inflammation in extremely preterm newborns. Endocrine. 2015 Mar; 48(2):595-602.
  22. Logan JW, Allred EN, Fichorova RN, Engelke S, Dammann O, Leviton A. Endogenous erythropoietin varies significantly with inflammation-related proteins in extremely premature newborns. Cytokine. 2014 Sep; 69(1):22-8.
  23. Allred EN, Capone A, Fraioli A, Dammann O, Droste P, Duker J, Gise R, Kuban K, Leviton A, O'Shea TM, Paneth N, Petersen R, Trese M, Stoessel K, Vanderveen D, Wallace DK, Weaver G. Retinopathy of prematurity and brain damage in the very preterm newborn. J AAPOS. 2014 Jun; 18(3):241-7.
  24. Sriram S, Condie J, Schreiber MD, Batton DG, Shah B, Bose C, Laughon M, Van Marter LJ, Allred EN, Leviton A. Early blood gas predictors of bronchopulmonary dysplasia in extremely low gestational age newborns. Int J Pediatr. 2014; 2014:210218.
  25. O'Shea TM, Joseph RM, Kuban KC, Allred EN, Ware J, Coster T, Fichorova RN, Dammann O, Leviton A. Elevated blood levels of inflammation-related proteins are associated with an attention problem at age 24 mo in extremely preterm infants. Pediatr Res. 2014 Jun; 75(6):781-7.
  26. Kuban KC, O'Shea TM, Allred EN, Paneth N, Hirtz D, Fichorova RN, Leviton A. Systemic inflammation and cerebral palsy risk in extremely preterm infants. J Child Neurol. 2014 Dec; 29(12):1692-8.
  27. Phadke A, Msall ME, Droste P, Allred EN, O'Shea TM, Kuban K, Dammann O, Leviton A. Impaired visual fixation at the age of 2 years in children born before the twenty-eighth week of gestation. Antecedents and correlates in the multicenter ELGAN study. Pediatr Neurol. 2014 Jul; 51(1):36-42.
  28. Maski KP, Loddenkemper T, An S, Allred EN, Urion DK, Leviton A. Development and implementation of a quality improvement curriculum for child neurology residents: lessons learned. Pediatr Neurol. 2014 May; 50(5):452-7.
  29. Dammann O, Leviton A. Intermittent or sustained systemic inflammation and the preterm brain. Pediatr Res. 2014 Mar; 75(3):376-80.
  30. Bartholomew J, Martin CR, Allred E, Chen ML, Ehrenkranz RA, Dammann O, Leviton A. Risk factors and correlates of neonatal growth velocity in extremely low gestational age newborns: the ELGAN Study. Neonatology. 2013; 104(4):298-304.
  31. Wei C, Lu Q, Khoo SK, Lenski M, Fichorova RN, Leviton A, Paneth N. Comparison of frozen and unfrozen blood spots for gene expression studies. J Pediatr. 2014 Jan; 164(1):189-191.e1.
  32. Boyd LA, Msall ME, O'Shea TM, Allred EN, Hounshell G, Leviton A. Social-emotional delays at 2 years in extremely low gestational age survivors: correlates of impaired orientation/engagement and emotional regulation. Early Hum Dev. 2013 Dec; 89(12):925-30.
  33. van der Burg JW, Allred EN, McElrath TF, Fichorova RN, Kuban K, O'Shea TM, Dammann O, Leviton A. Is maternal obesity associated with sustained inflammation in extremely low gestational age newborns? Early Hum Dev. 2013 Dec; 89(12):949-55.
  34. McElrath TF, Allred EN, Van Marter L, Fichorova RN, Leviton A. Perinatal systemic inflammatory responses of growth-restricted preterm newborns. Acta Paediatr. 2013 Oct; 102(10):e439-42.
  35. Adén U, Lin A, Carlo W, Leviton A, Murray JC, Hallman M, Lifton RP, Zhang H, Ment LR. Candidate gene analysis: severe intraventricular hemorrhage in inborn preterm neonates. J Pediatr. 2013 Nov; 163(5):1503-6.e1.
  36. Mane KK, Loddenkemper T, Fernández IS, Mikati MA, Tennison M, Schmitt C, Wilhelmsen K, Leviton A. Visual aids to medical data and computational diagnostics: new frontiers in pediatric neurology. Epilepsy Behav. 2013 Aug; 28(2):258-60.
  37. VanderVeen DK, Martin CR, Mehendale R, Allred EN, Dammann O, Leviton A. Early nutrition and weight gain in preterm newborns and the risk of retinopathy of prematurity. PLoS One. 2013; 8(5):e64325.
  38. Leviton A, Loddenkemper T, Pomeroy SL. Clinical practice guidelines and practice parameters for the child neurologist. J Child Neurol. 2013 Jul; 28(7):917-25.
  39. Allred E, An S, Leviton A, Loddenkemper T, McCrave J, Nichol SM. Should readmission within 30 days after discharge of children hospitalized for a neurologic disorder be considered a quality assurance failure? J Child Neurol. 2013 Jun; 28(6):758-61.
  40. Lee JW, McElrath T, Chen M, Wallace DK, Allred EN, Leviton A, Dammann O. Pregnancy disorders appear to modify the risk for retinopathy of prematurity associated with neonatal hyperoxemia and bacteremia. J Matern Fetal Neonatal Med. 2013 May; 26(8):811-8.
  41. O'Shea TM, Shah B, Allred EN, Fichorova RN, Kuban KC, Dammann O, Leviton A. Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants. Brain Behav Immun. 2013 Mar; 29:104-12.
  42. Leviton A, Fichorova RN, O'Shea TM, Kuban K, Paneth N, Dammann O, Allred EN. Two-hit model of brain damage in the very preterm newborn: small for gestational age and postnatal systemic inflammation. Pediatr Res. 2013 Mar; 73(3):362-70.
  43. Bose CL, Laughon MM, Allred EN, O'Shea TM, Van Marter LJ, Ehrenkranz RA, Fichorova RN, Leviton A. Systemic inflammation associated with mechanical ventilation among extremely preterm infants. Cytokine. 2013 Jan; 61(1):315-22.
  44. Martin CR, Bellomy M, Allred EN, Fichorova RN, Leviton A. Systemic inflammation associated with severe intestinal injury in extremely low gestational age newborns. Fetal Pediatr Pathol. 2013 Jun; 32(3):222-34.
  45. Leviton A. Why the term neonatal encephalopathy should be preferred over neonatal hypoxic-ischemic encephalopathy. Am J Obstet Gynecol. 2013 Mar; 208(3):176-80.
  46. Tyler CP, Paneth N, Allred EN, Hirtz D, Kuban K, McElrath T, O'Shea TM, Miller C, Leviton A. Brain damage in preterm newborns and maternal medication: the ELGAN Study. Am J Obstet Gynecol. 2012 Sep; 207(3):192.e1-9.
  47. Streimish IG, Ehrenkranz RA, Allred EN, O'Shea TM, Kuban KC, Paneth N, Leviton A. Birth weight- and fetal weight-growth restriction: impact on neurodevelopment. Early Hum Dev. 2012 Sep; 88(9):765-71.
  48. Helderman JB, O'Shea TM, Kuban KC, Allred EN, Hecht JL, Dammann O, Paneth N, McElrath TF, Onderdonk A, Leviton A. Antenatal antecedents of cognitive impairment at 24 months in extremely low gestational age newborns. Pediatrics. 2012 Mar; 129(3):494-502.
  49. Trivedi S, Joachim M, McElrath T, Kliman HJ, Allred EN, Fichorova RN, Onderdonk A, Heitor F, Chaychi L, Leviton A, Majzoub JA. Fetal-placental inflammation, but not adrenal activation, is associated with extreme preterm delivery. Am J Obstet Gynecol. 2012 Mar; 206(3):236.e1-8.
  50. Tolsma KW, Allred EN, Chen ML, Duker J, Leviton A, Dammann O. Neonatal bacteremia and retinopathy of prematurity: the ELGAN study. Arch Ophthalmol. 2011 Dec; 129(12):1555-63.
  51. Leviton A, Nichol SM, Allred EN, Loddenkemper T. What is quality improvement and why should child neurologists care? J Child Neurol. 2012 Feb; 27(2):251-7.
  52. Chen ML, Allred EN, Hecht JL, Onderdonk A, VanderVeen D, Wallace DK, Leviton A, Dammann O. Placenta microbiology and histology and the risk for severe retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2011 Sep 01; 52(10):7052-8.
  53. Leviton A, Allred EN, Kuban KC, Dammann O, Fichorova RN, O'Shea TM, Paneth N. Blood protein concentrations in the first two postnatal weeks associated with early postnatal blood gas derangements among infants born before the 28th week of gestation. The ELGAN Study. Cytokine. 2011 Nov; 56(2):392-8.
  54. Leviton A, Hecht JL, Allred EN, Yamamoto H, Fichorova RN, Dammann O. Persistence after birth of systemic inflammation associated with umbilical cord inflammation. J Reprod Immunol. 2011 Aug; 90(2):235-43.
  55. Leviton A, Brumback RA. Quality improvement specific for child neurology. J Child Neurol. 2011 Jun; 26(6):673-4.
  56. Faupel-Badger JM, Fichorova RN, Allred EN, Hecht JL, Dammann O, Leviton A, McElrath TF. Cluster analysis of placental inflammatory proteins can distinguish preeclampsia from preterm labor and premature membrane rupture in singleton deliveries less than 28 weeks of gestation. Am J Reprod Immunol. 2011 Dec; 66(6):488-94.
  57. Luyster RJ, Kuban KC, O'Shea TM, Paneth N, Allred EN, Leviton A. The Modified Checklist for Autism in Toddlers in extremely low gestational age newborns: individual items associated with motor, cognitive, vision and hearing limitations. Paediatr Perinat Epidemiol. 2011 Jul; 25(4):366-76.
  58. McElrath TF, Fichorova RN, Allred EN, Hecht JL, Ismail MA, Yuan H, Leviton A. Blood protein profiles of infants born before 28 weeks differ by pregnancy complication. Am J Obstet Gynecol. 2011 May; 204(5):418.e1-418.e12.
  59. Fichorova RN, Onderdonk AB, Yamamoto H, Delaney ML, DuBois AM, Allred E, Leviton A. Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. MBio. 2011 Jan 18; 2(1):e00280-10.
  60. Logan JW, O'Shea TM, Allred EN, Laughon MM, Bose CL, Dammann O, Batton DG, Engelke SC, Leviton A. Early postnatal hypotension and developmental delay at 24 months of age among extremely low gestational age newborns. Arch Dis Child Fetal Neonatal Ed. 2011 Sep; 96(5):F321-8.
  61. Dammann O, Leviton A. The challenge of causal inference. Ann Neurol. 2010 Nov; 68(5):770.
  62. Leviton A, Dammann O, Engelke S, Allred E, Kuban KC, O'Shea TM, Paneth N. The clustering of disorders in infants born before the 28th week of gestation. Acta Paediatr. 2010 Dec; 99(12):1795-800.
  63. Leviton A, Allred E, Kuban KC, Dammann O, O'Shea TM, Hirtz D, Schreiber MD, Paneth N. Early blood gas abnormalities and the preterm brain. Am J Epidemiol. 2010 Oct 15; 172(8):907-16.
  64. Van Marter LJ, Kuban KC, Allred E, Bose C, Dammann O, O'Shea M, Laughon M, Ehrenkranz RA, Schreiber MD, Karna P, Leviton A. Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation? Arch Dis Child Fetal Neonatal Ed. 2011 Jan; 96(1):F20-9.
  65. Laughon M, Bose C, Allred EN, O'Shea TM, Ehrenkranz RA, Van Marter LJ, Leviton A. Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2011 Mar; 96(2):F114-20.
  66. Loddenkemper T, Nichol SM, Allred EN, Leviton A. Fears and promises of comparative effectiveness research. Acta Paediatr. 2010 Sep; 99(9):1311-3.
  67. Martin CR, Dammann O, Allred EN, Patel S, O'Shea TM, Kuban KC, Leviton A. Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia. J Pediatr. 2010 Nov; 157(5):751-6.e1.
  68. Peck JD, Leviton A, Cowan LD. A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: a 2000-2009 update. Food Chem Toxicol. 2010 Oct; 48(10):2549-76.
  69. Leviton A. Even tension-type headaches doesn't sound right. Acta Paediatr. 2008 Oct; 97(10):1344-5.
  70. McElrath TF, Hecht JL, Dammann O, Boggess K, Onderdonk A, Markenson G, Harper M, Delpapa E, Allred EN, Leviton A. Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification. Am J Epidemiol. 2008 Nov 1; 168(9):980-9.
  71. Hecht JL, Onderdonk A, Delaney M, Allred EN, Kliman HJ, Zambrano E, Pflueger SM, Livasy CA, Bhan I, Leviton A. Characterization of chorioamnionitis in 2nd-trimester C-section placentas and correlation with microorganism recovery from subamniotic tissues. Pediatr Dev Pathol. 2008 Jan-Feb; 11(1):15-22.
  72. Onderdonk AB, Delaney ML, DuBois AM, Allred EN, Leviton A. Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol. 2008 Jan; 198(1):110.e1-7.
  73. Leviton A, Gressens P. Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci. 2007 Sep; 30(9):473-8.
  74. Leviton A, Kuban K, Paneth N. Intraventricular haemorrhage grading scheme: time to abandon? Acta Paediatr. 2007 Sep; 96(9):1254-6.
  75. Hecht JL, Kliman HJ, Allred EN, Pflueger SM, Chang CH, Doss BJ, Roberts D, Livasy CA, Bhan I, Zambrano E, Ross DW, Senagore P, Husain AN, Leviton A. Reference weights for placentas delivered before the 28th week of gestation. Placenta. 2007 Oct; 28(10):987-90.
  76. Leviton A. Motivated reasoning. Acta Paediatr. 2007 Jul; 96(7):949.
  77. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007 Feb; 109:8-14.
  78. Cohen J, Van Marter LJ, Sun Y, Allred E, Leviton A, Kohane IS. Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia. Genome Biol. 2007; 8(10):R210.
  79. Dammann O, Leviton A. Perinatal brain damage causation. Dev Neurosci. 2007; 29(4-5):280-8.
  80. Leviton A. The discourteous reviewer. Paediatr Perinat Epidemiol. 2007 Jan; 21(1):2-4.
  81. Dammann O, Leviton A. Neuroimaging and the prediction of outcomes in preterm infants. N Engl J Med. 2006 Aug 17; 355(7):727-9.
  82. Dammann O, Leviton A. Periventricular leukomalacia might not specifically affect cortical magnetoencephalographic response to biological motion. Ann Neurol. 2006 Aug; 60(2):269; author reply 269-70.
  83. Nelson KB, Leviton A. Hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2006 Apr 13; 354(15):1643-5; author reply 1643-5.
  84. Dammann O, Leviton A. Inflammation, brain damage and visual dysfunction in preterm infants. Semin Fetal Neonatal Med. 2006 Oct; 11(5):363-8.
  85. Leviton A, Dammann O, Durum SK. The adaptive immune response in neonatal cerebral white matter damage. Ann Neurol. 2005 Dec; 58(6):821-8.
  86. Kuban KC, O'Shea M, Allred E, Leviton A, Gilmore H, DuPlessis A, Krishnamoorthy K, Hahn C, Soul J, O'Connor SE, Miller K, Church PT, Keller C, Bream R, Adair R, Miller A, Romano E, Bassan H, Kerkering K, Engelke S, Marshall D, Milowic K, Wereszczak J, Hubbard C, Washburn L, Dillard R, Heller C, Burdo-Hartman W, Fagerman L, Sutton D, Karna P, Olomu N, Caldarelli L, Oca M, Lohr K, Scheiner A. Video and CD-ROM as a training tool for performing neurologic examinations of 1-year-old children in a multicenter epidemiologic study. J Child Neurol. 2005 Oct; 20(10):829-31.
  87. Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, Jacobsson B, Damiano D. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol. 2005 Aug; 47(8):571-6.
  88. Dammann O, Leviton A, Gappa M, Dammann CE. Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/inflammation and long term outcome. BJOG. 2005 Mar; 112 Suppl 1:4-9.
  89. Martin CR, Van Marter LJ, Allred EN, Leviton A. Antenatal glucocorticoids increase early total thyroxine levels in premature infants. Biol Neonate. 2005; 87(4):273-80.
  90. Leviton A, Blair E, Dammann O, Allred E. The wealth of information conveyed by gestational age. J Pediatr. 2005 Jan; 146(1):123-7.
  91. Hagberg H, Dammann O, Mallard C, Leviton A. Preconditioning and the developing brain. Semin Perinatol. 2004 Dec; 28(6):389-95.
  92. Dammann O, Allred EN, Leviton A, Shen-Schwarz S, Heller D, Genest DR, Collins MH. Fetal vasculitis in preterm newborns: interrelationships, modifiers, and antecedents. Placenta. 2004 Nov; 25(10):788-96.
  93. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns--dry numbers, wet lab, and causal inferences. Early Hum Dev. 2004 Aug; 79(1):1-15.
  94. Dammann O, Leviton A, Bartels DB, Dammann CE. Lung and brain damage in preterm newborns. Are they related? How? Why? Biol Neonate. 2004; 85(4):305-13.
  95. Gilles FH, Tavaré CJ, Leviton A, Hedley-Whyte ET, Sotrel A, Adelman L, Davis RL, Rorke LB. Prognostic limitations of the Daumas-Duport grading scheme in infratentorial neuroglial tumors in children. Pediatr Dev Pathol. 2004 Mar-Apr; 7(2):138-47.
  96. Leviton A, Dammann O. Coagulation, inflammation, and the risk of neonatal white matter damage. Pediatr Res. 2004 Apr; 55(4):541-5.
  97. Dammann O, Leviton A. Biomarker epidemiology of cerebral palsy. Ann Neurol. 2004 Feb; 55(2):158-61.
  98. Leviton A, Dammann O, O'Shea TM, Paneth N. Adult stroke and perinatal brain damage: like grandparent, like grandchild? Neuropediatrics. 2002 Dec; 33(6):281-7.
  99. Leviton A, Holmes LB, Allred EN, Vargas J. Methodologic issues in epidemiologic studies of congenital microcephaly. Early Hum Dev. 2002 Oct; 69(1-2):91-105.
  100. Gilles FH, Leviton A, Tavaré CJ, Adelman L, Rorke LB, Sobel EL, Hedley-Whyte ET, Davis RL. Clinical and survival covariates of eight classes of childhood supratentorial neuroglial tumors. Cancer. 2002 Sep 15; 95(6):1302-10.
  101. Leviton A, Cowan L. A review of the literature relating caffeine consumption by women to their risk of reproductive hazards. Food Chem Toxicol. 2002 Sep; 40(9):1271-310.
  102. Leviton A, Stewart JE, Allred EN, Dammann O, Kuban K. Neurological sequelae in in-vitro fertilisation babies. Lancet. 2002 Aug 31; 360(9334):718; author reply 719.
  103. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, Martin C. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr. 2002 Feb; 140(2):171-6.
  104. Dammann O, Allred EN, Kuban KC, Van Marter LJ, Pagano M, Sanocka U, Leviton A. Systemic hypotension and white-matter damage in preterm infants. Dev Med Child Neurol. 2002 Feb; 44(2):82-90.
  105. Dammann O, Kuban KC, Leviton A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment Retard Dev Disabil Res Rev. 2002; 8(1):46-50.
  106. Leviton A, Dammann O. Brain damage markers in children. Neurobiological and clinical aspects. Acta Paediatr. 2002; 91(1):9-13.
  107. Martin CR, Van Marter LJ, Allred EN, Leviton A. Growth-restricted premature infants are at increased risk for low thyroxine. Early Hum Dev. 2001 Sep; 64(2):119-28.
  108. Leviton A, Allred EN, Dammann O, Kuban K, Martin CR. Broad-spectrum antibiotics in ORACLE. Lancet. 2001 Aug 11; 358(9280):502; author reply 503-4.
  109. Vargas JE, Allred EN, Leviton A, Holmes LB. Congenital microcephaly: phenotypic features in a consecutive sample of newborn infants. J Pediatr. 2001 Aug; 139(2):210-4.
  110. Dammann O, Durum S, Leviton A. Do white cells matter in white matter damage? Trends Neurosci. 2001 Jun; 24(6):320-4.
  111. Dammann O, Hagberg H, Leviton A. Is periventricular leukomalacia an axonopathy as well as an oligopathy? Pediatr Res. 2001 Apr; 49(4):453-7.
  112. Dammann O, Leviton A. Possible strategies to protect the preterm brain against the fetal inflammatory response. Dev Med Child Neurol Suppl. 2001 Mar; 86:18-20.
  113. Dammann O, Phillips TM, Allred EN, O'Shea TM, Paneth N, Van Marter LJ, Bose C, Ehrenkranz RA, Bednarek FJ, Naples M, Leviton A. Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine. 2001 Feb 21; 13(4):234-9.
  114. Van Marter LJ, Allred EN, Leviton A, Pagano M, Parad R, Moore M. Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr. 2001 Feb; 138(2):198-204.
  115. Hansen AR, Collins MH, Genest D, Heller D, Schwarz S, Banagon P, Allred EN, Leviton A. Very low birthweight Infant's placenta and its relation to pregnancy and fetal characteristics. Pediatr Dev Pathol. 2000 Sep-Oct; 3(5):419-30.
  116. Hansen AR, Collins MH, Genest D, Heller D, Shen-Schwarz S, Banagon P, Allred EN, Leviton A. Very low birthweight placenta: clustering of morphologic characteristics. Pediatr Dev Pathol. 2000 Sep-Oct; 3(5):431-8.
  117. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, Leviton A. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics. 2000 Jun; 105(6):1194-201.
  118. Dammann O, Leviton A. Brain damage in preterm newborns: biological response modification as a strategy to reduce disabilities. J Pediatr. 2000 Apr; 136(4):433-8.
  119. Dammann O, Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr. 2000 Apr; 12(2):99-104.
  120. Gilles FH, Brown WD, Leviton A, Tavaré CJ, Adelman L, Rorke LB, Davis RL, Hedley-Whyte TE. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor Consortium. Cancer. 2000 Mar 15; 88(6):1477-83.
  121. Gilles FH, Leviton A, Tavaré CJ, Adelman L, Rorke LB, Sobel EL, Hedley-Whyte ET, Davis RL. Definitive classes of childhood supratentorial neuroglial tumors. The Childhood Brain Tumor Consortium. Pediatr Dev Pathol. 2000 Mar-Apr; 3(2):126-39.
  122. Dammann O, Leviton A. Placental cytokine expression in preterm labour and the fetal inflammatory response. Cytokine. 2000 Feb; 12(2):176-7.
  123. Dammann O, Leviton A, Allred EN. What explains away the increased risk of histological chorioamnionitis in African-American mothers of very-low-birthweight infants? Developmental Epidemiology Network Investigators. Paediatr Perinat Epidemiol. 2000 Jan; 14(1):20-9.
  124. Cowan LD, Leviton A, Dammann O. New research directions in neuroepidemiology. Epidemiol Rev. 2000; 22(1):18-23.
  125. Dammann O, Leviton A. Brain damage in preterm newborns: might enhancement of developmentally regulated endogenous protection open a door for prevention? Pediatrics. 1999 Sep; 104(3 Pt 1):541-50.
  126. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, Kuban K, Van Marter LJ, Pagano M. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr. 1999 Jun; 134(6):706-11.
  127. Brown WD, Gilles FH, Tavaré CJ, Rorke LB, Davis RL, Adelman L, Hedley-Whyte ET, Leviton A. Prognostic limitations of the Daumas-Duport grading scheme in childhood supratentorial astroglial tumors. J Neuropathol Exp Neurol. 1998 Nov; 57(11):1035-40.
  128. Gilles FH, Leviton A, Golden JA, Paneth N, Rudelli RD. Groups of histopathologic abnormalities in brains of very low birthweight infants. J Neuropathol Exp Neurol. 1998 Nov; 57(11):1026-34.
  129. Dammann O, Leviton A. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol. 1998 Sep; 5(3):190-201.
  130. Leviton A. Heavy caffeine consumption in pregnancy, smoking, and sudden infant death syndrome. Arch Dis Child. 1998 Sep; 79(3):291.
  131. Gilles FH, Sobel EL, Leviton A, Tavaré CJ. Clusters of histologic characteristics in children with infratentorial neuroglial tumors. The Childhood Brain Tumor Consortium. J Neurooncol. 1998 Aug; 39(1):51-63.
  132. Dammann O, Leviton A. Is some white matter damage in preterm neonates induced by a human pestivirus? Arch Dis Child Fetal Neonatal Ed. 1998 May; 78(3):F230-1.
  133. Murphy KE, Reuss ML, Leviton A, Paneth N, Susser M. Variation in use of corticosteroids among infants &lt or = 1,500 grams across hospitals in three states. J Matern Fetal Med. 1998 May-Jun; 7(3):137-41.
  134. Dammann O, Leviton A. Does prepregnancy bacterial vaginosis increase a mother's risk of having a preterm infant with cerebral palsy? Dev Med Child Neurol. 1997 Dec; 39(12):836-40.
  135. Reuss ML, Leviton A, Paneth N, Susser M. Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation. Am J Public Health. 1997 Oct; 87(10):1693-7.
  136. Gilles FH, Sobel EL, Leviton A, Tavaré CJ, Hedley-Whyte ET, Rorke L, Adelman L, Sobel R. Quantitative histologic factors for grouping childhood infratentorial neuroglial tumors. Pediatr Pathol Lab Med. 1997 Sep-Oct; 17(5):809-34.
  137. Sobel EL, Gilles FH, Tavaré CJ, Leviton A, Hedley-Whyte ET. Prognosis for children with supratentorial neuroglial tumors. Pediatr Pathol Lab Med. 1997 Sep-Oct; 17(5):755-67.
  138. Hansen AR, Allred EN, Leviton A. Predictors of ventriculoperitoneal shunt among babies with intraventricular hemorrhage. J Child Neurol. 1997 Sep; 12(6):381-6.
  139. Gilles FH, Sobel EL, Leviton A, Tavaré CJ, Hedley-Whyte ET. Quantitative histologic factors for grouping childhood supratentorial neuroglial tumors. Pediatr Pathol Lab Med. 1997 Sep-Oct; 17(5):729-54.
  140. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 1997 Jul; 42(1):1-8.
  141. Allred EN, Dammann O, Kuban K, Leviton A, Pagano M. Neonatal risk factors for cerebral palsy in very preterm babies. Time oriented analyses of risk are useful. BMJ. 1997 May 31; 314(7094):1624.
  142. Golden JA, Gilles FH, Rudelli R, Leviton A. Frequency of neuropathological abnormalities in very low birth weight infants. J Neuropathol Exp Neurol. 1997 May; 56(5):472-8.
  143. Allred EN, Dammann O, Kuban KK, Leviton A, Pagano M, Stewart JE, VanMarter LJ. Prenatal magnesium sulfate exposure and risk of cerebral palsy. JAMA. 1997 Apr 2; 277(13):1033-4.
  144. Leviton A. Re: Effects of caffeine consumption on delayed conception. Am J Epidemiol. 1996 Oct 15; 144(8):800-1.
  145. Leviton A, Gilles F. Ventriculomegaly, delayed myelination, white matter hypoplasia, and "periventricular" leukomalacia: how are they related? Pediatr Neurol. 1996 Sep; 15(2):127-36.
  146. Sobel EL, Gilles FH, Leviton A, Tavaré CJ, Hedley-Whyte ET, Rorke LB, Adelman LS. Survival of children with infratentorial neuroglial tumors. The Childhood Brain Tumor Consortium. Neurosurgery. 1996 Jul; 39(1):45-54; discussion 54-6.
  147. Levy HL, Waisbren SE, Lobbregt D, Allred E, Leviton A, Koch R, Hanley WB, Rouse B, Matalon R, de la Cruz F. Maternal non-phenylketonuric mild hyperphenylalaninemia. Eur J Pediatr. 1996 Jul; 155 Suppl 1:S20-5.
  148. Leviton A. Coffee consumption and residual confounding. Epidemiology. 1996 Jan; 7(1):110-11.
  149. Kundsin RB, Leviton A, Allred EN, Poulin SA. Ureaplasma urealyticum infection of the placenta in pregnancies that ended prematurely. Obstet Gynecol. 1996 Jan; 87(1):122-7.
  150. Gilles FH, Sobel EL, Tavaré CJ, Leviton A, Hedley-Whyte ET. Age-related changes in diagnoses, histological features, and survival in children with brain tumors: 1930-1979. The Childhood Brain Tumor Consortium. Neurosurgery. 1995 Dec; 37(6):1056-68.
  151. Leviton A, Bellinger D, Pagano M, Rabinowitz M. Models of delayed recovery. J Child Neurol. 1995 Sep; 10(5):385-91.
  152. Leviton A. The perinatal paradox. Am J Public Health. 1995 Jul; 85(7):906-7.
  153. Garland JS, Buck RK, Allred EN, Leviton A. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome. Arch Pediatr Adolesc Med. 1995 Jun; 149(6):617-22.
  154. Leviton A. Trans fatty acid and coronary disease: the debate continues. 1. The use of population attributable risk. Am J Public Health. 1995 Mar; 85(3):410; author reply 412-3.
  155. Greene MF, Allred EN, Leviton A. Maternal metabolic control and risk of microcephaly among infants of diabetic mothers. Diabetes Care. 1995 Feb; 18(2):166-9.
  156. Leviton A. Does coffee consumption increase the risk of reproductive adversities? J Am Med Womens Assoc. 1995 Jan-Feb; 50(1):20-2.
  157. Gilles FH, Sobel EL, Leviton A, Tavaré CJ, Hedley-Whyte ET. Histologic feature reliability in childhood neural tumors. Childhood Brain Tumor Consortium. J Neuropathol Exp Neurol. 1994 Nov; 53(6):559-71.
  158. Leviton A, Allred EN. Correlates of decaffeinated coffee choice. Epidemiology. 1994 Sep; 5(5):537-40.
  159. Bellinger D, Leviton A, Allred E, Rabinowitz M. Pre- and postnatal lead exposure and behavior problems in school-aged children. Environ Res. 1994 Jul; 66(1):12-30.
  160. Gold EB, Leviton A, Lopez R, Austin DF, Gilles FH, Hedley-Whyte ET, Kolonel LN, Lyon JL, Swanson GM, Weiss NS, et al. The role of family history in risk of childhood brain tumors. Cancer. 1994 Feb 15; 73(4):1302-11.
  161. Chen TC, Leviton A. Headache recurrence in pregnant women with migraine. Headache. 1994 Feb; 34(2):107-10.
  162. Kuban KC, Leviton A. Cerebral palsy. N Engl J Med. 1994 Jan 20; 330(3):188-95.
  163. Leviton A, Needleman H, Bellinger D, Allred EN. Children with hypoplastic enamel defects of primary incisors are not at increased risk of learning-problem syndromes. ASDC J Dent Child. 1994 Jan-Feb; 61(1):35-8.
  164. Rabinowitz MB, Leviton A, Bellinger D. Relationships between serial blood lead levels and exfoliated tooth dentin lead levels: models of tooth lead kinetics. Calcif Tissue Int. 1993 Nov; 53(5):338-41.
  165. Leviton A, Kuban KC, Pagano M, Allred EN, Van Marter L. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns. Pediatrics. 1993 Jun; 91(6):1083-8.
  166. Leviton A. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev Med Child Neurol. 1993 Jun; 35(6):553-8.
  167. Gold EB, Leviton A, Lopez R, Gilles FH, Hedley-Whyte ET, Kolonel LN, Lyon JL, Swanson GM, Weiss NS, West D, et al. Parental smoking and risk of childhood brain tumors. Am J Epidemiol. 1993 Mar 15; 137(6):620-8.
  168. Leviton A, Guild-Wilson M, Neff RK, Gambill P. The Boston Teacher Questionnaire. 1. Definition of syndromes. J Child Neurol. 1993 Jan; 8(1):43-53.
  169. Leviton A, Kirby C, Guild-Wilson M, Neff RK. The Boston Teacher Questionnaire. 2. Assessments of validity. J Child Neurol. 1993 Jan; 8(1):54-63.
  170. Leviton A, Bellinger D, Allred EN, Rabinowitz M, Needleman H, Schoenbaum S. Pre- and postnatal low-level lead exposure and children's dysfunction in school. Environ Res. 1993 Jan; 60(1):30-43.
  171. Leviton A, Bellinger D, Allred E. The Boston Teacher Questionnaire. 3. A reassessment. J Child Neurol. 1993 Jan; 8(1):64-72.
  172. Gilles FH, Leviton A, Hedley-Whyte ET, Sobel E, Tavaré CJ, Sobel RS, Rorke LB. Childhood brain tumors that occupy more than one compartment at presentation. Multiple compartment tumors. J Neurooncol. 1992 Sep; 14(1):45-56.
  173. Gilles FH, Sobel EL, Leviton A, Hedley-Whyte ET, Tavare CJ, Adelman L, Sobel RA. Temporal trends among childhood brain tumor biopsies. The Childhood Brain Tumor Consortium. J Neurooncol. 1992 Jun; 13(2):137-49.
  174. Van Marter LJ, Pagano M, Allred EN, Leviton A, Kuban KC. Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J Pediatr. 1992 Jun; 120(6):938-46.
  175. Needleman HL, Allred E, Bellinger D, Leviton A, Rabinowitz M, Iverson K. Antecedents and correlates of hypoplastic enamel defects of primary incisors. Pediatr Dent. 1992 May-Jun; 14(3):158-66.
  176. Conaway MR, Waternaux C, Allred E, Bellinger D, Leviton A. Pre-natal blood lead levels and learning difficulties in children: an analysis of non-randomly missing categorical data. Stat Med. 1992 Apr; 11(6):799-811.
  177. Leviton A, Nelson KB. Problems with definitions and classifications of newborn encephalopathy. Pediatr Neurol. 1992 Mar-Apr; 8(2):85-90.
  178. Gilles FH, Sobel E, Leviton A, Hedley-Whyte ET, Tavare CJ, Adelman LS, Sobel RA. Epidemiology of seizures in children with brain tumors. The Childhood Brain Tumor Consortium. J Neurooncol. 1992 Jan; 12(1):53-68.
  179. Kuban KC, Leviton A, Pagano M, Fenton T, Strassfeld R, Wolff M. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol. 1992 Jan; 7(1):70-6.
  180. Leviton A. Study on PMS and caffeine consumption flawed. Am J Public Health. 1991 Dec; 81(12):1673-5.
  181. Nelson KB, Leviton A. How much of neonatal encephalopathy is due to birth asphyxia? Am J Dis Child. 1991 Nov; 145(11):1325-31.
  182. Rabinowitz MB, Bellinger D, Leviton A, Wang JD. Lead levels among various deciduous tooth types. Bull Environ Contam Toxicol. 1991 Oct; 47(4):602-8.
  183. Needleman HL, Leviton A, Allred E. Macroscopic enamel defects of primary anterior teeth--types, prevalence, and distribution. Pediatr Dent. 1991 Jul-Aug; 13(4):208-16.
  184. Bellinger D, Leviton A, Rabinowitz M, Allred E, Needleman H, Schoenbaum S. Weight gain and maturity in fetuses exposed to low levels of lead. Environ Res. 1991 Apr; 54(2):151-8.
  185. Bellinger D, Sloman J, Leviton A, Rabinowitz M, Needleman HL, Waternaux C. Low-level lead exposure and children's cognitive function in the preschool years. Pediatrics. 1991 Feb; 87(2):219-27.
  186. Leviton A, Fenton T, Kuban KC, Pagano M. Labor and delivery characteristics and the risk of germinal matrix hemorrhage in low birth weight infants. J Child Neurol. 1991 Jan; 6(1):35-40.
  187. Bellinger D, Leviton A, Sloman J. Antecedents and correlates of improved cognitive performance in children exposed in utero to low levels of lead. Environ Health Perspect. 1990 Nov; 89:5-11.
  188. Chen TC, Leviton A. Asthma and eczema in children born to women with migraine. Arch Neurol. 1990 Nov; 47(11):1227-30.
  189. Leviton A, Paneth N. White matter damage in preterm newborns--an epidemiologic perspective. Early Hum Dev. 1990 Oct; 24(1):1-22.
  190. Pagano M, Leviton A, Kuban K. Early and late germinal matrix hemorrhage may have different antecedents. Eur J Obstet Gynecol Reprod Biol. 1990 Oct; 37(1):47-54.
  191. Van Marter LJ, Leviton A, Kuban KC, Pagano M, Allred EN. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics. 1990 Sep; 86(3):331-6.
  192. Sussman A, Leviton A, Allred EN, Aschenbrener C, Austin DF, Gilles FH, Hedley-Whyte ET, Kolonel LN, Lyon JL, Swanson GM, et al. Childhood brain tumor: presentation at younger age is associated with a family tumor history. Cancer Causes Control. 1990 Jul; 1(1):75-9.
  193. Leviton M, Leviton J, Leviton A. Educational infant care and the public health. Am J Public Health. 1990 Jul; 80(7):790-1.
  194. Krishnamoorthy KS, Kuban KC, Leviton A, Brown ER, Sullivan KF, Allred EN. Periventricular-intraventricular hemorrhage, sonographic localization, phenobarbital, and motor abnormalities in low birth weight infants. Pediatrics. 1990 Jun; 85(6):1027-33.
  195. Van Marter LJ, Leviton A, Allred EN, Pagano M, Kuban KC. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J Pediatr. 1990 Jun; 116(6):942-9.
  196. Leviton A. Methylxanthine consumption and the risk of ovarian malignancy. Cancer Lett. 1990 May 30; 51(2):91-101.
  197. Neff RK, Leviton A. Maternal theophylline consumption and the risk of stillbirth. Chest. 1990 May; 97(5):1266-7.
  198. Rabinowitz MB, Allred EN, Bellinger DC, Leviton A, Needleman HL. Lead and childhood propensity to infectious and allergic disorders: is there an association? Bull Environ Contam Toxicol. 1990 May; 44(5):657-60.
  199. Leviton A, Cowan L, Kuban K. Epilepsy and suicide. Arch Neurol. 1990 Apr; 47(4):381-2.
  200. Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med. 1990 Jan 11; 322(2):83-8.
  201. Pagano M, Leviton A. File drawers, p values and efficacy of drugs. J Clin Epidemiol. 1990; 43(9):1012-4.
  202. Leviton A, VanMarter L, Kuban KC. Respiratory distress syndrome and intracranial hemorrhage: cause or association? Inferences from surfactant clinical trials. Pediatrics. 1989 Nov; 84(5):915-22.
  203. Rabinowitz MB, Leviton A, Bellinger DC. Blood lead--tooth lead relationship among Boston children. Bull Environ Contam Toxicol. 1989 Oct; 43(4):485-92.
  204. Leviton A. Neurologic sequelae of pertussis immunization--1989. J Child Neurol. 1989 Oct; 4(4):311-4.
  205. Cowan LD, Leviton A, Bodensteiner JB, Doherty L. Problems in estimating the prevalence of epilepsy in children: the yield from different sources of information. Paediatr Perinat Epidemiol. 1989 Oct; 3(4):386-401.
  206. Bellinger D, Leviton A, Waternaux C. Lead, IQ and social class. Int J Epidemiol. 1989 Mar; 18(1):180-5.
  207. Cowan LD, Bodensteiner JB, Leviton A, Doherty L. Prevalence of the epilepsies in children and adolescents. Epilepsia. 1989 Jan-Feb; 30(1):94-106.
  208. Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M. Low-level lead exposure, social class, and infant development. Neurotoxicol Teratol. 1988 Nov-Dec; 10(6):497-503.
  209. Kuban KC, Skouteli H, Cherer A, Brown E, Leviton A, Pagano M, Allred E, Sullivan KF. Hemorrhage, phenobarbital, and fluctuating cerebral blood flow velocity in the neonate. Pediatrics. 1988 Oct; 82(4):548-53.
  210. Leviton A, Kuban KC, Pagano M, Brown ER, Krishnamoorthy KS, Allred EN. Maternal toxemia and neonatal germinal matrix hemorrhage in intubated infants less than 1751 g. Obstet Gynecol. 1988 Oct; 72(4):571-6.
  211. Leviton A, Pagano M, Kuban KC. Etiologic heterogeneity of intracranial hemorrhages in preterm newborns. Pediatr Neurol. 1988 Sep-Oct; 4(5):274-8.
  212. Epstein MF, Leviton A, Kuban KC, Pagano M, Meltzer C, Skouteli HN, Brown ER, Sullivan KF. Bilirubin, intraventricular hemorrhage, and phenobarbital in very low birth weight babies. Pediatrics. 1988 Sep; 82(3):350-4.
  213. Bodensteiner JB, Brownsworth RD, Knapik JR, Kanter MC, Cowan LD, Leviton A. Interobserver variability in the ILAE classification of seizures in childhood. Epilepsia. 1988 Mar-Apr; 29(2):123-8.
  214. Slack WV, Leviton A, Bennett SE, Fleischmann KH, Lawrence RS. Relation between age, education, and time to respond to questions in a computer-based medical interview. Comput Biomed Res. 1988 Feb; 21(1):78-84.
  215. Leviton A. Caffeine consumption and the risk of reproductive hazards. J Reprod Med. 1988 Feb; 33(2):175-8.
  216. Skouteli HN, Kuban KC, Leviton A, Brown ER, Krishnamoorthy KS, Pagano M, Allred EN, Sullivan KF, Baglivo JA, Huff KR, et al. Arterial blood gas derangements associated with death and intracranial hemorrhage in premature babies. J Perinatol. 1988; 8(4):336-41.
  217. Leviton A. Single-cause attribution. Dev Med Child Neurol. 1987 Dec; 29(6):805-7.
  218. Rabinowitz M, Bellinger D, Leviton A, Needleman H, Schoenbaum S. Pregnancy hypertension, blood pressure during labor, and blood lead levels. Hypertension. 1987 Oct; 10(4):447-51.
  219. Chen TC, Leviton A, Edelstein S, Ellenberg JH. Migraine and other diseases in women of reproductive age. The influence of smoking on observed associations. Arch Neurol. 1987 Oct; 44(10):1024-8.
  220. Leviton A, Baglivo J, Kuban KC, Brown ER, Krishnamoorthy KC. The prophylactic clinical trial as a epidemiologic resource. Control Clin Trials. 1987 Sep; 8(3):243-54.
  221. Kuban KC, Leviton A, Brown ER, Krishnamoorthy K, Baglivo J, Sullivan KF, Allred E. Respiratory complications in low-birth-weight infants who received phenobarbital. Am J Dis Child. 1987 Sep; 141(9):996-9.
  222. Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med. 1987 Apr 23; 316(17):1037-43.
  223. Leviton A. Perinatal asphyxia. Pediatr Neurol. 1987 Mar-Apr; 3(2):123.
  224. Leviton A. Dyslipoproteinemia and migraine. Pediatrics. 1986 Nov; 78(5):956-7.
  225. Leviton A. Do learning handicaps and headache cluster? J Child Neurol. 1986 Oct; 1(4):372-7.
  226. Olshan AF, Breslow NE, Daling JR, Weiss NS, Leviton A. Childhood brain tumors and paternal occupation in the aerospace industry. J Natl Cancer Inst. 1986 Jul; 77(1):17-9.
  227. Bellinger D, Leviton A, Rabinowitz M, Needleman H, Waternaux C. Correlates of low-level lead exposure in urban children at 2 years of age. Pediatrics. 1986 Jun; 77(6):826-33.
  228. Rabinowitz MB, Leviton A, Needleman HL. Occurrence of elevated protoporphyrin levels in relation to lead burden in infants. Environ Res. 1986 Apr; 39(2):253-7.
  229. Kuban KC, Leviton A, Krishnamoorthy KS, Brown ER, Teele RL, Baglivo JA, Sullivan KF, Huff KR, White S, Cleveland RH, et al. Neonatal intracranial hemorrhage and phenobarbital. Pediatrics. 1986 Apr; 77(4):443-50.
  230. Bellinger D, Leviton A, Needleman HL, Waternaux C, Rabinowitz M. Low-level lead exposure and infant development in the first year. Neurobehav Toxicol Teratol. 1986 Mar-Apr; 8(2):151-61.
  231. Leviton A, Kuban K. Ultrasound scans of brain in pre-term infants. Lancet. 1986 Jan 18; 1(8473):161.
  232. Mueller M, Leviton A. In-home versus clinic-based services for the developmentally disabled child: who is the primary client--parent or child? Soc Work Health Care. 1986; 11(3):75-88.
  233. Leviton A, Bellinger D. Consequences of unremitting middle-ear infection in early life. N Engl J Med. 1985 Nov 21; 313(21):1353-4.
  234. Bellinger D, Leviton A, Waternaux C, Allred E. Methodological issues in modeling the relationship between low-level lead exposure and infant development: examples from the Boston Lead Study. Environ Res. 1985 Oct; 38(1):119-29.
  235. Rabinowitz M, Leviton A, Needleman H, Bellinger D, Waternaux C. Environmental correlates of infant blood lead levels in Boston. Environ Res. 1985 Oct; 38(1):96-107.
  236. Rabinowitz M, Leviton A, Needleman H. Lead in milk and infant blood: a dose-response model. Arch Environ Health. 1985 Sep-Oct; 40(5):283-6.
  237. Deymeer F, Leviton A. Perinatal factors and seizure disorders: an epidemiologic review. Epilepsia. 1985 Jul-Aug; 26(4):287-98.
  238. Rabinowitz M, Leviton A, Bellinger D. Home refinishing, lead paint, and infant blood lead levels. Am J Public Health. 1985 Apr; 75(4):403-4.
  239. Leviton A, Gilles F. Pre- and postnatal bacterial infections as risk factors of the perinatal leucoencephalopathies. Prog Clin Biol Res. 1985; 163B:75-9.
  240. Deymeer F, Leviton A. Posttraumatic seizures: an assessment of the epidemiologic literature. Cent Nerv Syst Trauma. 1985; 2(1):33-43.
  241. Bellinger DC, Needleman HL, Leviton A, Waternaux C, Rabinowitz MB, Nichols ML. Early sensory-motor development and prenatal exposure to lead. Neurobehav Toxicol Teratol. 1984 Sep-Oct; 6(5):387-402.
  242. Leviton A. To what extent does food sensitivity contribute to headache recurrence? Dev Med Child Neurol. 1984 Aug; 26(4):542-5.
  243. Leviton A, Gilles FH. Acquired perinatal leukoencephalopathy. Ann Neurol. 1984 Jul; 16(1):1-8.
  244. Leviton A, Slack WV, Bana D, Graham JR. Age-related headache characteristics. Arch Neurol. 1984 Jul; 41(7):762-4.
  245. Leviton A, Slack WV, Masek B, Bana D, Graham JR. A computerized behavioral assessment for children with headaches. Headache. 1984 Jul; 24(2):182-5.
  246. Needleman HL, Rabinowitz M, Leviton A, Linn S, Schoenbaum S. The relationship between prenatal exposure to lead and congenital anomalies. JAMA. 1984 Jun 8; 251(22):2956-9.
  247. Leviton A. Epidemiology: use and utility in the process. Fundam Appl Toxicol. 1984 Jun; 4(3 Pt 2):S357-66.
  248. Rabinowitz M, Leviton A, Needleman H. Variability of blood lead concentrations during infancy. Arch Environ Health. 1984 Mar-Apr; 39(2):74-7.
  249. Gilles FH, Leviton A, Hedley-Whyte T, Jasnow M. Childhood brain tumor update. Hum Pathol. 1983 Oct; 14(10):834-45.
  250. Needleman HL, Leviton A, Bellinger D. Lead-associated intellectual deficit. N Engl J Med. 1982 Feb 11; 306(6):367.
  251. Needleman HL, Bellinger D, Leviton A. Does lead at low dose affect intelligence in children? Pediatrics. 1981 Dec; 68(6):894-6.
  252. Leviton A, Gilles F. Periventricular leukomalacia. Arch Neurol. 1981 Jun; 38(6):398.
  253. Bana DS, Leviton A, Slack WV, Geer DE, Graham JR. Use of a computerized data base in a headache clinic. Headache. 1981 Mar; 21(2):72-4.
  254. Leviton A, Cowan LD. Methodological issues in the epidemiology of seizure disorders in children. Epidemiol Rev. 1981; 3:67-89.
  255. Porter D, Leviton A, Slack WV, Graham JR. A headache chronicle: the daily recording of headaches and their correlates. J Chronic Dis. 1981; 34(9-10):481-6.
  256. Schulman J, Leviton A, Slack W, Porter D, Graham JR. The relationship of headache occurrence to barometric pressure. Int J Biometeorol. 1980 Sep; 24(3):263-9.
  257. Leviton A. Otitis media and learning disorders. J Dev Behav Pediatr. 1980 Jun; 1(2):58-63.
  258. Leviton A, Gilles F. Periventricular hemorrhage in the newborn. Neurology. 1980 Jun; 30(6):677-9.
  259. Bana DS, Leviton A, Swidler C, Slack W, Graham JR. A computer-based headache interview: acceptance by patients and physicians. Headache. 1980 Mar; 20(2):85-9.
  260. Leviton A, Schulman J, Kammerman L, Porter D, Slack W, Graham JR. A probability model of headache recurrence. J Chronic Dis. 1980; 33(7):407-12.
  261. Shonkoff JP, Dworkin PH, Leviton A, Levine MD. Primary care approaches to developmental disabilities. Pediatrics. 1979 Oct; 64(4):506-14.
  262. Leviton A, Gilles F. Maternal urinary-tract infections and fetal leukoencephalopathy. N Engl J Med. 1979 Sep 20; 301(12):661.
  263. Needleman HL, Leviton A. Lead and neurobehavioural deficit in children. Lancet. 1979 Jul 14; 2(8133):104.
  264. Wilkinson WE, Heyman A, Burch JG, Ostfeld A, Labarthe DR, Leviton A, O'Fallon WM, Whisnant J. Use of a self-administered questionnaire for detection of transient cerebral ischemic attacks: I. Survey of elderly persons living in retirement facilities. Ann Neurol. 1979 Jul; 6(1):40-6.
  265. Leviton A, Graham P. Headache rounds--acquired migraine. Headache. 1979 Jul; 19(5):254-6.
  266. Dworkin PH, Shonkoff JP, Leviton A, Levine MD. Training in developmental pediatrics. How practitioners perceive the gap. Am J Dis Child. 1979 Jul; 133(7):709-12.
  267. Needleman HL, Gunnoe C, Leviton A, Reed R, Peresie H, Maher C, Barrett P. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med. 1979 Mar 29; 300(13):689-95.
  268. Needleman HL, Leviton A. Neurologic effects of exposure to lead. J Pediatr. 1979 Mar; 94(3):505-6.
  269. Leviton A, Kilty T. Seasonal variation in the birth of left-handed schoolgirls. Arch Neurol. 1979 Feb; 36(2):115-6.
  270. Leviton A, Gilles F, Dooling E. Epidemiology of periventricular leukomalacia. Trans Am Neurol Assoc. 1979; 104:168-72.
  271. Leviton A, Gilles FH, Vawter GF. The thymus in infants with perinatal telencephalic leukoencephalopathy. Arch Neurol. 1978 Jun; 35(6):377-81.
  272. Gilles F, Winston K, Jasnow M, Leviton A, Hedley-Whyte T. Densely cellular cerebellar tumors in children. Trans Am Neurol Assoc. 1978; 103:265-8.
  273. Leviton A, Fulchiero A, Gilles FH, Winston K. Survival status of children with cerebellar gliomas. J Neurosurg. 1978 Jan; 48(1):29-33.
  274. Leviton A, Gilles F, Strassfeld R. The influence of route of delivery and hyaline membranes on the risk of neonatal intracranial hemorrhages. Ann Neurol. 1977 Dec; 2(6):451-4.
  275. Leviton A, Epidem SM, Gilles FH. Limitations of autopsy data in relating neonatal intracranial hemorrhage to buffer therapy. Hum Pathol. 1977 Nov; 8(6):599-601.
  276. Fulchiero A, Winston K, Leviton A, Gilles FH. Secular trends of cerebellar gliomas in children. J Natl Cancer Inst. 1977 Apr; 58(4):839-43.
  277. Winston K, Gilles FH, Leviton A, Fulchiero A. Cerebellar gliomas in children. J Natl Cancer Inst. 1977 Apr; 58(4):833-8.
  278. Duchowny M, Leviton A. Methylphenidate therapy for inattentiveness in selected school children. Ann Neurol. 1977 Mar; 1(3):307-8.
  279. Gilles FH, Winston K, Fulchiero A, Leviton A. Histologic features and observational variation in cerebellar gliomas in children. J Natl Cancer Inst. 1977 Feb; 58(2):175-81.
  280. Leviton A, Gilles FH, Dooling ED, Fulchiero A. Risk factors of delayed myelination in the newborn. Trans Am Neurol Assoc. 1977; 102:39-41.
  281. Leviton A, Gilles F, Neff R, Yaney P. Multivariate analysis of risk of perinatal telencephalic leucoencephalopathy. Am J Epidemiol. 1976 Dec; 104(6):621-6.
  282. Brott T, Leviton A. Violence. Headache. 1976 Nov; 16(5):203-9.
  283. Leviton A, Kilty T. Letter: Birth order and left-handedness. Arch Neurol. 1976 Sep; 33(9):664.
  284. Leviton A, Schulman J. Reaction times and Digit Symbol Test scores of girls identified as daydreamers by their teachers. Percept Mot Skills. 1976 Aug; 43(1):239-44.
  285. Gilles FH, Leviton A, Kerr CS. Endotoxin leucoencephalopathy in the telencephalon of the newborn kitten. J Neurol Sci. 1976 Feb; 27(2):183-91.
  286. Leviton A, Gilles FH, Strassfeld R. Cesarian section and the risk of neonatal intracranial hemorrhage. Trans Am Neurol Assoc. 1976; 101:121-4.
  287. Leviton A, Caplan L, Salzman E. Severe headache after carotid endarterectomy. Headache. 1975 Oct; 15(3):207-10.
  288. Schifrin BS, Lapidus M, Doctor GS, Leviton A. Contraction stress test for antepartum fetal evaluation. Obstet Gynecol. 1975 Apr; 45(4):433-8.
  289. Leviton A. "Headache rounds": post carotid-endarterectomy "hemicrania". Headache. 1975 Apr; 15(1):13-7.
  290. Gilles FH, Leviton A, Dooling EC. Letter: Intracranial hemorrhage in infants. N Engl J Med. 1974 Nov 14; 291(20):1088.
  291. Leviton A, Gilles FH. Astrocytosis without globules in infant cerebral white matter. An epidemiologic study. J Neurol Sci. 1974 Jul; 22(3):329-40.
  292. Leviton A, Gilles FH. Morphologic abnormalities in human infant cerebral white matter related to gestational and postnatal age. Pediatr Res. 1974 Jul; 8(7):718-20.
  293. Leviton A, Malvea B, Graham JR. Vascular diseases, mortality, and migraine in the parents of migraine patients. Neurology. 1974 Jul; 24(7):669-72.
  294. Leviton A. Letter: Definitions of attributable risk. Am J Epidemiol. 1973 Sep; 98(3):231.
  295. Leviton A, Gilles FH. Are hypertrophic astrocytes a sufficient criterion of perinatal telencephalic leucoencephalopathy? J Neurol Neurosurg Psychiatry. 1973 Jun; 36(3):383-8.
  296. Leviton A, Gilles FH. An epidemiologic study of perinatal telencephalic leucoencephalopathy in an autopsy population. J Neurol Sci. 1973 Jan; 18(1):53-66.
  297. Leviton A, Davidson R, Gilles F. Neurologic manifestations of embryonal rhabdomyosarcoma of the middle ear cleft. J Pediatr. 1972 Apr; 80(4):596-602.
  298. Leviton A, Gilles FH. Morphologic correlates of age at death of infants with perinatal telencephalic leukoencephalopathy. Am J Pathol. 1971 Nov; 65(2):303-9.
  299. Leviton A, Gilles FH. Custering of the morphological components of perinatal telencephalic leucoencephalopathy. J Neurol Neurosurg Psychiatry. 1971 Oct; 34(5):642-5.
  300. Leviton A. Fatty-acid metabolism in migraine. Lancet. 1971 Jul 3; 2(7714):48.
  301. Leviton A, Gilles FH. Neonatal white matter vulnerability: changes with time. Trans Am Neurol Assoc. 1971; 96:269-70.
  302. Leviton A, Camenga D. Migraine associated with hyper-pre-beta lipoproteinemia. Neurology. 1969 Oct; 19(10):963-6.
  303. Leviton A. Behavioral correlates of caffeine consumption by children. Clin Pediatr (Phila). 1992 Dec; 31(12):742-50.
  304. Leviton A, Kuban K. Ventricular dilatation in preterm infants. Pediatr Neurol. 1993 Nov-Dec; 9(6):498.
  305. Kuban JD, Allred EN, Leviton A. Thymus involution and cerebral white matter damage in extremely low gestational age neonates. Biol Neonate. 2006; 90(4):252-7.
  306. Laughon M, Bose C, Allred E, O'Shea TM, Van Marter LJ, Bednarek F, Leviton A. Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week. Pediatrics. 2007 Feb; 119(2):273-80.
  307. Kuban KC, O'Shea TM, Allred EN, Tager-Flusberg H, Goldstein DJ, Leviton A. Positive screening on the Modified Checklist for Autism in Toddlers (M-CHAT) in extremely low gestational age newborns. J Pediatr. 2009 Apr; 154(4):535-540.e1.
  308. Leviton A, Allred EN, Yamamoto H, Fichorova RN. Relationships among the concentrations of 25 inflammation-associated proteins during the first postnatal weeks in the blood of infants born before the 28th week of gestation. Cytokine. 2012 Jan; 57(1):182-90.
  309. Holling EE, Leviton A. Characteristics of cranial ultrasound white-matter echolucencies that predict disability: a review. Dev Med Child Neurol. 1999 Feb; 41(2):136-9.
  310. Dammann O, Allred EN, Van Marter LJ, Dammann CE, Leviton A. Bronchopulmonary dysplasia is not associated with ultrasound-defined cerebral white matter damage in preterm newborns. Pediatr Res. 2004 Feb; 55(2):319-25.
  311. Leviton A, Paneth N, Susser M, Reuss ML, Allred EN, Kuban K, Sanocka U, Hegyi T, Hiatt M, Shahrivar F, Van Marter LJ. Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage. Pediatrics. 1997 Apr; 99(4):E2.
  312. O'Shea TM, Allred EN, Kuban KC, Hirtz D, Specter B, Durfee S, Paneth N, Leviton A. Intraventricular hemorrhage and developmental outcomes at 24 months of age in extremely preterm infants. J Child Neurol. 2012 Jan; 27(1):22-9.
  313. Laughon M, Bose C, Allred EN, O'shea TM, Ehrenkranz RA, VAN Marter LJ, Leviton A. Patterns of blood protein concentrations of ELGANs classified by three patterns of respiratory disease in the first 2 postnatal weeks. Pediatr Res. 2011 Sep; 70(3):292-6.
  314. Hansen AR, DiSalvo D, Kazam E, Allred EN, Leviton A. Sonographically detected subarachnoid hemorrhage: an independent predictor of neonatal posthemorrhagic hydrocephalus? Clin Imaging. 2000 May-Jun; 24(3):121-9.
  315. McElrath TF, Allred EN, Leviton A. Prolonged latency after preterm premature rupture of membranes: an evaluation of histologic condition and intracranial ultrasonic abnormality in the neonate born at &lt28 weeks of gestation. Am J Obstet Gynecol. 2003 Sep; 189(3):794-8.
  316. Hecht JL, Allred EN, Kliman HJ, Zambrano E, Doss BJ, Husain A, Pflueger SM, Chang CH, Livasy CA, Roberts D, Bhan I, Ross DW, Senagore PK, Leviton A. Histological characteristics of singleton placentas delivered before the 28th week of gestation. Pathology. 2008 Jun; 40(4):372-6.
  317. Dammann O, Leviton A. Duration of transient hyperechoic images of white matter in very-low-birthweight infants: a proposed classification. Dev Med Child Neurol. 1997 Jan; 39(1):2-5.
  318. Hansen A, Leviton A. Labor and delivery characteristics and risks of cranial ultrasonographic abnormalities among very-low-birth-weight infants. The Developmental Epidemiology Network Investigators. Am J Obstet Gynecol. 1999 Oct; 181(4):997-1006.
  319. SanGiovanni JP, Allred EN, Mayer DL, Stewart JE, Herrera MG, Leviton A. Reduced visual resolution acuity and cerebral white matter damage in very-low-birthweight infants. Dev Med Child Neurol. 2000 Dec; 42(12):809-15.
  320. Kuban K, Adler I, Allred EN, Batton D, Bezinque S, Betz BW, Cavenagh E, Durfee S, Ecklund K, Feinstein K, Fordham LA, Hampf F, Junewick J, Lorenzo R, McCauley R, Miller C, Seibert J, Specter B, Wellman J, Westra S, Leviton A. Observer variability assessing US scans of the preterm brain: the ELGAN study. Pediatr Radiol. 2007 Dec; 37(12):1201-8.
  321. McElrath TF, Allred EN, Kuban K, Hecht JL, Onderdonk A, O'Shea TM, Paneth N, Leviton A. Factors associated with small head circumference at birth among infants born before the 28th week. Am J Obstet Gynecol. 2010 Aug; 203(2):138.e1-8.
  322. Kuban K, Sanocka U, Leviton A, Allred EN, Pagano M, Dammann O, Share J, Rosenfeld D, Abiri M, DiSalvo D, Doubilet P, Kairam R, Kazam E, Kirpekar M, Schonfeld S. White matter disorders of prematurity: association with intraventricular hemorrhage and ventriculomegaly. The Developmental Epidemiology Network. J Pediatr. 1999 May; 134(5):539-46.
  323. Olomu IN, Hecht JL, Onderdonk AO, Allred EN, Leviton A. Perinatal correlates of Ureaplasma urealyticum in placenta parenchyma of singleton pregnancies that end before 28 weeks of gestation. Pediatrics. 2009 May; 123(5):1329-36.
  324. O'Shea TM, Kuban KC, Allred EN, Paneth N, Pagano M, Dammann O, Bostic L, Brooklier K, Butler S, Goldstein DJ, Hounshell G, Keller C, McQuiston S, Miller A, Pasternak S, Plesha-Troyke S, Price J, Romano E, Solomon KM, Jacobson A, Westra S, Leviton A. Neonatal cranial ultrasound lesions and developmental delays at 2 years of age among extremely low gestational age children. Pediatrics. 2008 Sep; 122(3):e662-9.
  325. Kuban KC, Allred EN, O'Shea M, Paneth N, Pagano M, Leviton A. An algorithm for identifying and classifying cerebral palsy in young children. J Pediatr. 2008 Oct; 153(4):466-72.
  326. Leviton A, Kuban K, Allred EN, Hecht JL, Onderdonk A, O'Shea TM, McElrath T, Paneth N. Antenatal antecedents of a small head circumference at age 24-months post-term equivalent in a sample of infants born before the 28th post-menstrual week. Early Hum Dev. 2010 Aug; 86(8):515-21.
  327. Krishnamoorthy KS, Kuban KC, O'Shea TM, Westra SJ, Allred EN, Leviton A. Early cranial ultrasound lesions predict microcephaly at age 2 years in preterm infants. J Child Neurol. 2011 Feb; 26(2):188-94.
  328. Leviton A, Pagano M, Kuban KC, Krishnamoorthy KS, Sullivan KF, Allred EN. The epidemiology of germinal matrix hemorrhage during the first half-day of life. Dev Med Child Neurol. 1991 Feb; 33(2):138-45.
  329. Onderdonk AB, Hecht JL, McElrath TF, Delaney ML, Allred EN, Leviton A. Colonization of second-trimester placenta parenchyma. Am J Obstet Gynecol. 2008 Jul; 199(1):52.e1-52.e10.
  330. Hauspurg AK, Allred EN, Vanderveen DK, Chen M, Bednarek FJ, Cole C, Ehrenkranz RA, Leviton A, Dammann O. Blood gases and retinopathy of prematurity: the ELGAN Study. Neonatology. 2011; 99(2):104-11.
  331. Leviton A, Kuban K, O'Shea TM, Paneth N, Fichorova R, Allred EN, Dammann O. The relationship between early concentrations of 25 blood proteins and cerebral white matter injury in preterm newborns: the ELGAN study. J Pediatr. 2011 Jun; 158(6):897-903.e1-5.
  332. Dammann O, Shah B, Naples M, Bednarek F, Zupancic J, Allred EN, Leviton A. Interinstitutional variation in prediction of death by SNAP-II and SNAPPE-II among extremely preterm infants. Pediatrics. 2009 Nov; 124(5):e1001-6.
  333. Laughon M, Allred EN, Bose C, O'Shea TM, Van Marter LJ, Ehrenkranz RA, Leviton A. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics. 2009 Apr; 123(4):1124-31.
  334. Bose C, Laughon M, Allred EN, Van Marter LJ, O'Shea TM, Ehrenkranz RA, Fichorova R, Leviton A. Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation. Pediatr Res. 2011 Apr; 69(4):347-53.
  335. Dammann O, Allred EN, Genest DR, Kundsin RB, Leviton A. Antenatal mycoplasma infection, the fetal inflammatory response and cerebral white matter damage in very-low-birthweight infants. Paediatr Perinat Epidemiol. 2003 Jan; 17(1):49-57.
  336. Dammann O, Naples M, Bednarek F, Shah B, Kuban KC, O'Shea TM, Paneth N, Allred EN, Leviton A. SNAP-II and SNAPPE-II and the risk of structural and functional brain disorders in extremely low gestational age newborns: the ELGAN study. Neonatology. 2010; 97(2):71-82.
  337. Laughon M, O'Shea MT, Allred EN, Bose C, Kuban K, Van Marter LJ, Ehrenkranz RA, Leviton A. Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation. Pediatrics. 2009 Aug; 124(2):637-48.
  338. Dammann O, Allred EN, Kuban KC, van Marter LJ, Stewart JE, Pagano M, Leviton A. Hypocarbia during the first 24 postnatal hours and white matter echolucencies in newborns &lt or = 28 weeks gestation. Pediatr Res. 2001 Mar; 49(3):388-93.
  339. Leviton A, Dammann O, Allred EN, Kuban K, Pagano M, Van Marter L, Paneth N, Reuss ML, Susser M. Antenatal corticosteroids and cranial ultrasonographic abnormalities. Am J Obstet Gynecol. 1999 Oct; 181(4):1007-17.
  340. Patel S, Dammann O, Martin CR, Allred EN, Leviton A. Presumed and definite bacteremia in extremely low gestational age newborns. Acta Paediatr. 2011 Jan; 100(1):36-41.
  341. Westra S, Adler I, Batton D, Betz B, Bezinque S, Durfee S, Ecklund K, Feinstein K, Fordham L, Junewick J, Lorenzo R, McCauley R, Miller C, Seibert J, Kuban K, Allred E, Leviton A. Reader variability in the use of diagnostic terms to describe white matter lesions seen on cranial scans of severely premature infants: the ELGAN study. J Clin Ultrasound. 2010 Oct; 38(8):409-19.
  342. Kuban KC, Allred EN, O'Shea TM, Paneth N, Pagano M, Dammann O, Leviton A, Du Plessis A, Westra SJ, Miller CR, Bassan H, Krishnamoorthy K, Junewick J, Olomu N, Romano E, Seibert J, Engelke S, Karna P, Batton D, O'Connor SE, Keller CE. Cranial ultrasound lesions in the NICU predict cerebral palsy at age 2 years in children born at extremely low gestational age. J Child Neurol. 2009 Jan; 24(1):63-72.
  343. Bose C, Van Marter LJ, Laughon M, O'Shea TM, Allred EN, Karna P, Ehrenkranz RA, Boggess K, Leviton A. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics. 2009 Sep; 124(3):e450-8.
  344. Garland JS, Buck R, Leviton A. Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactant-treated preterm infants. J Pediatr. 1995 Feb; 126(2):272-9.
  345. O'Shea TM, Allred EN, Dammann O, Hirtz D, Kuban KC, Paneth N, Leviton A. The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev. 2009 Nov; 85(11):719-25.
  346. Leviton A, O'Shea TM, Bednarek FJ, Allred EN, Fichorova RN, Dammann O. Systemic responses of preterm newborns with presumed or documented bacteraemia. Acta Paediatr. 2012 Apr; 101(4):355-9.
  347. Dammann O, Bueter W, Leviton A, Gressens P, Dammann CE. Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage. Neonatology. 2008; 93(3):182-7.
  348. Leviton A. Epidemiology of headache. Adv Neurol. 1978; 19:341-53.
  349. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, Kuban K, Van Marter LJ, Pagano M, Hegyi T, Hiatt M, Sanocka U, Shahrivar F, Abiri M, Disalvo D, Doubilet P, Kairam R, Kazam E, Kirpekar M, Rosenfeld D, Schonfeld S, Share J, Collins M, Genest D, Shen-Schwarz S, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res. 1999 Nov; 46(5):566-75.
  350. Kuban KC, Allred EN, O'Shea TM, Paneth N, Westra S, Miller C, Rosman NP, Leviton A. Developmental correlates of head circumference at birth and two years in a cohort of extremely low gestational age newborns. J Pediatr. 2009 Sep; 155(3):344-9.e1-3.
  351. Van Marter LJ, Leviton A, Allred EN, Pagano M, Sullivan KF, Cohen A, Epstein MF. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics. 1996 May; 97(5):658-63.
  352. Martin CR, Brown YF, Ehrenkranz RA, O'Shea TM, Allred EN, Belfort MB, McCormick MC, Leviton A. Nutritional practices and growth velocity in the first month of life in extremely premature infants. Pediatrics. 2009 Aug; 124(2):649-57.
  353. Leviton A, Fichorova R, Yamamoto Y, Allred EN, Dammann O, Hecht J, Kuban K, McElrath T, O'Shea TM, Paneth N. Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. Cytokine. 2011 Jan; 53(1):66-73.
  354. Stewart JE, Allred EN, Collins M, Abbott J, Leviton A, Paneth N, Reuss ML, Susser M, Hegyi T, Hiatt M, Sanocka U, Shahrivar F, Van Marter LJ, Banogan P, Genest D, Heller D, Shen-Schwarz S, Dammann O, Kuban KC, Pagano M. Risk of cranial ultrasound abnormalities in very-low-birth-weight infants conceived with assisted reproductive techniques. J Perinatol. 2002 Jan; 22(1):37-45.
  355. Bueter W, Dammann O, Leviton A. Endoplasmic reticulum stress, inflammation, and perinatal brain damage. Pediatr Res. 2009 Nov; 66(5):487-94.
  356. Kuban KC, Allred EN, Dammann O, Pagano M, Leviton A, Share J, Abiri M, Di Salvo D, Doubilet P, Kairam R, Kazam E, Kirpekar M, Rosenfeld DL, Sanocka UM, Schonfeld SM. Topography of cerebral white-matter disease of prematurity studied prospectively in 1607 very-low-birthweight infants. J Child Neurol. 2001 Jun; 16(6):401-8.
  357. Hecht JL, Fichorova RN, Tang VF, Allred EN, McElrath TF, Leviton A. Relationship Between Neonatal Blood Protein Concentrations and Placenta Histologic Characteristics in Extremely Low GA Newborns. Pediatr Res. 2011 Jan; 69(1):68-73.
  358. Logan JW, O'Shea TM, Allred EN, Laughon MM, Bose CL, Dammann O, Batton DG, Kuban KC, Paneth N, Leviton A. Early postnatal hypotension is not associated with indicators of white matter damage or cerebral palsy in extremely low gestational age newborns. J Perinatol. 2011 Aug; 31(8):524-34.
  359. Fein RL, Chait A, Leviton A. Renal vein thrombectomy for the treatment of renal vein thrombosis associated with the neophrotic syndrome. J Urol. 1968 Jan; 99(1):1-13.
  360. Leviton A, Kuban KC, Allred EN, Fichorova RN, O'Shea TM, Paneth N. Early postnatal blood concentrations of inflammation-related proteins and microcephaly two years later in infants born before the 28th post-menstrual week. Early Hum Dev. 2011 May; 87(5):325-30.
  361. O'Shea TM, Allred EN, Kuban KC, Dammann O, Paneth N, Fichorova R, Hirtz D, Leviton A. Elevated concentrations of inflammation-related proteins in postnatal blood predict severe developmental delay at 2 years of age in extremely preterm infants. J Pediatr. 2012 Mar; 160(3):395-401.e4.
  362. Adler I, Batton D, Betz B, Bezinque S, Ecklund K, Junewick J, McCauley R, Miller C, Seibert J, Specter B, Westra S, Leviton A. Mechanisms of injury to white matter adjacent to a large intraventricular hemorrhage in the preterm brain. J Clin Ultrasound. 2010 Jun; 38(5):254-8.
  363. McElrath TF, Allred EN, Boggess KA, Kuban K, O'Shea TM, Paneth N, Leviton A. Maternal antenatal complications and the risk of neonatal cerebral white matter damage and later cerebral palsy in children born at an extremely low gestational age. Am J Epidemiol. 2009 Oct 1; 170(7):819-28.
  364. Leviton A, Allred EN, Kuban KC, Hecht JL, Onderdonk AB, O'shea TM, Paneth N. Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. the ELGAN study. Pediatr Res. 2010 Jan; 67(1):95-101.
  365. Logan JW, Westra SJ, Allred EN, O'Shea TM, Kuban K, Paneth N, Leviton A. Antecedents of perinatal cerebral white matter damage with and without intraventricular hemorrhage in very preterm newborns. Pediatr Neurol. 2013 Aug; 49(2):88-96.
  366. Leviton A, Allred EN, Dammann O, Engelke S, Fichorova RN, Hirtz D, Kuban KC, Ment LR, O'shea TM, Paneth N, Shah B, Schreiber MD. Systemic inflammation, intraventricular hemorrhage, and white matter injury. J Child Neurol. 2013 Dec; 28(12):1637-45.
  367. Holm M, Msall ME, Skranes J, Dammann O, Allred E, Leviton A. Antecedents and correlates of visual field deficits in children born extremely preterm. Eur J Paediatr Neurol. 2015 Jan; 19(1):56-63.
  368. Frazier JA, Wood ME, Ware J, Joseph RM, Kuban KC, O'Shea M, Allred EN, Leviton A. Antecedents of the child behavior checklist-dysregulation profile in children born extremely preterm. J Am Acad Child Adolesc Psychiatry. 2015 Oct; 54(10):816-23.
  369. Leviton A, Allred EN, Kuban KC, O'Shea TM, Paneth N, Majzoub J. Brain disorders associated with corticotropin-releasing hormone expression in the placenta among children born before the 28th week of gestation. Acta Paediatr. 2016 Jan; 105(1):e7-11.
  370. van der Burg JW, Sen S, Chomitz VR, Seidell JC, Leviton A, Dammann O. The role of systemic inflammation linking maternal BMI to neurodevelopment in children. Pediatr Res. 2016 Jan; 79(1-1):3-12.
  371. Leviton A, Allred EN, Fichorova RN, Kuban KC, Michael O'Shea T, Dammann O. Systemic inflammation on postnatal days 21 and 28 and indicators of brain dysfunction 2years later among children born before the 28th week of gestation. Early Hum Dev. 2016 Feb; 93:25-32.
  372. VanderVeen DK, Allred EN, Wallace DK, Leviton A. Strabismus at Age 2 Years in Children Born Before 28 Weeks' Gestation: Antecedents and Correlates. J Child Neurol. 2016 Mar; 31(4):451-60.
  373. Joseph RM, Korzeniewski SJ, Allred EN, O'Shea TM, Heeren T, Frazier JA, Ware J, Hirtz D, Leviton A, Kuban K. Extremely low gestational age and very low birthweight for gestational age are risk factors for autism spectrum disorder in a large cohort study of 10-year-old children born at 23-27 weeks' gestation. Am J Obstet Gynecol. 2016 Nov 12.
  374. Kim SH, Joseph RM, Frazier JA, O'Shea TM, Chawarska K, Allred EN, Leviton A, Kuban KK. Predictive Validity of the Modified Checklist for Autism in Toddlers (M-CHAT) Born Very Preterm. J Pediatr. 2016 Nov; 178:101-107.e2.
LIke ThisLIke ThisLIke This
Close